These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16684216)

  • 1. Sorbent suspensions vs. sorbent columns for extracorporeal detoxification in hepatic failure.
    Ash SR; Sullivan TA; Carr DJ
    Ther Apher Dial; 2006 Apr; 10(2):145-53. PubMed ID: 16684216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy.
    Ash SR
    Adv Ren Replace Ther; 2002 Jan; 9(1):3-18. PubMed ID: 11927902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
    Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
    Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure.
    Evenepoel P; Laleman W; Wilmer A; Claes K; Maes B; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
    Blood Purif; 2005; 23(5):349-58. PubMed ID: 16020951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver support technology--an update.
    Rozga J
    Xenotransplantation; 2006 Sep; 13(5):380-9. PubMed ID: 16925661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a multifunctional detoxifying unit for liver failure patients.
    Lee K; Mun CH; Min BG
    Blood Purif; 2012; 34(3-4):225-30. PubMed ID: 23171622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin regeneration in liver support-comparison of different methods.
    Mitzner S; Klammt S; Stange J; Schmidt R
    Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorbent-based artificial liver devices: principles of operation, chemical effects and clinical results.
    Carpentier B; Ash SR
    Expert Rev Med Devices; 2007 Nov; 4(6):839-61. PubMed ID: 18035950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
    Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
    Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Powdered sorbent liver dialysis and pheresis in treatment of hepatic failure.
    Ash SR
    Ther Apher; 2001 Oct; 5(5):404-16. PubMed ID: 11778927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
    Chiu A; Chan LM; Fan ST
    Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging indications for albumin dialysis.
    Sen S; Williams R; Jalan R
    Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.
    Roth GA; Faybik P; Hetz H; Hacker S; Ankersmit HJ; Bacher A; Thalhammer T; Krenn CG
    Dig Liver Dis; 2009 Jun; 41(6):417-23. PubMed ID: 19019743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can liver toxins be removed? Filtration and adsorption with the Prometheus system.
    Vienken J; Christmann H
    Ther Apher Dial; 2006 Apr; 10(2):125-31. PubMed ID: 16684213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorbents in treatment of uremia: a short history and a great future.
    Ash SR
    Semin Dial; 2009; 22(6):615-22. PubMed ID: 20017831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of bound solute dialysis.
    Patzer J
    Ther Apher Dial; 2006 Apr; 10(2):118-24. PubMed ID: 16684212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearing of toxic substances: are there differences between the available liver support devices?
    Krisper P; Stadlbauer V; Stauber RE
    Liver Int; 2011 Sep; 31 Suppl 3():5-8. PubMed ID: 21824275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluidized bed adsorbent systems for extracorporeal liver support.
    Falkenhagen D; Brandl M; Hartmann J; Kellner KH; Posnicek T; Weber V
    Ther Apher Dial; 2006 Apr; 10(2):154-9. PubMed ID: 16684217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospectives for using the extracorporeal connection of a xenospleen in treating patients with liver cirrhosis and obstructive jaundice complicated by liver failure].
    Vakhidov AV; Kasymov ShZ; Kirichenko IP; Nazyrov FG; Kornienko VI; Akbarov MM
    Vestn Khir Im I I Grek; 1993; 150(1-2):90-2. PubMed ID: 7701715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of Mars therapy with and without transplantation in 101 patients with liver insufficiency.
    Koivusalo AM; Vakkuri A; Höckerstedt K; Isoniemi H
    Transplant Proc; 2005 Oct; 37(8):3315-7. PubMed ID: 16298584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.